Literature DB >> 29102076

Prevention of Surgical Site Infection: Analysis and Narrative Review of Clinical Practice Guidelines.

Francisco Javier Gómez-Romero1, Maria Fernández-Prada2, Juan Francisco Navarro-Gracia3.   

Abstract

Surgical site infection is one of the most prevalent healthcare-associated infections and presents a considerable morbidity. The aim of this comprehensive narrative review is to describe the evidence and grade of recommendation of the preventive measures developed in the three phases of the surgical process (preoperative, perioperative and postoperative phases), as well as coincidences and divergences between selected Clinical Practice Guidelines (CPG). Four preventive measures were recommended with similar high grade evidence in all CPG: Hair removal, antibiotic prophylaxis, surgical site preparation and normothermia. However, critical points, new preventive measures and bundle implementations by surgical process are under discussion. These results represent a significant progress toward improving programs to prevent surgical site infection and they should be taken into account for improved future interventions in this area.
Copyright © 2017 AEC. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Clinical practice guideline; Guía de práctica clínica; Infección de herida quirúrgica; Infección de sitio quirúrgico; Medidas preventivas de infección; Prevención y control; Prevention and control; Preventive infection measures; Surgical site infection; Surgical wound infection

Mesh:

Year:  2017        PMID: 29102076     DOI: 10.1016/j.ciresp.2017.09.004

Source DB:  PubMed          Journal:  Cir Esp        ISSN: 0009-739X            Impact factor:   1.653


  1 in total

1.  Intraoperative subcutaneous culture as a predictor of surgical site infection in open gynecological surgery.

Authors:  Ricardo Sainz de la Cuesta; Rosa Mohedano; Sylvia Sainz de la Cuesta; Belen Guzman; Alicia Serrera; Silvia Paulos; Margarita Rubio
Journal:  PLoS One       Date:  2021-01-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.